Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer
In spite of the huge advancements in both diagnosis and interventions, hormone refractory prostate cancer (HRPC) remains a major hurdle in prostate cancer (PCa). Metabolic reprogramming plays a key role in PCa oncogenesis and resistance. However, the dynamics between metabolism and oncogenesis are n...
Main Authors: | Ali Mokhtar Mahmoud, Magdalena Kostrzewa, Viviana Marolda, Marianna Cerasuolo, Federica Maccarinelli, Daniela Coltrini, Sara Rezzola, Arianna Giacomini, Maria Pina Mollica, Andrea Motta, Debora Paris, Antonio Zorzano, Vincenzo Di Marzo, Roberto Ronca, Alessia Ligresti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661823000397 |
Similar Items
-
Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge
by: Alessandra Di Salvo, et al.
Published: (2023-06-01) -
Are cannabidiol (CBD) levels in consumer food products well tested?—A review
by: Shahida Anusha Siddiqui, et al.
Published: (2023-12-01) -
THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet
by: Jonathan Gorelick, et al.
Published: (2022-05-01) -
Towards understanding of plant mitochondrial VDAC proteins: an overview of bean (<em>Phaseolus</em>) VDAC proteins
by: Hayet Saidani, et al.
Published: (2016-12-01) -
Non-Overlapping Distributions and Functions of the VDAC Family in Ciliogenesis
by: Shubhra Majumder, et al.
Published: (2015-07-01)